Diphenylamine

Diphenylamine

SCHEMBL1691353

C1CC1.c1ccc(Nc2ccccc2)cc1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 5/20 0.80
▸ TDP1 Q9NUW8 8/20 0.75
▸ ALDH1A1 P00352 7/20 0.75
▸ TSHR P16473 4/20 0.75
▸ ALOX12 P18054 3/20 0.75
▸ L3MBTL1 Q9Y468 3/20 0.75
▸ ALOX15 P16050 2/20 0.75
▸ MAPK1 P28482 2/20 0.75
▸ PTGS1 P23219 1/20 0.75
▸ SLC6A2 P23975 1/20 0.75
▸ PTGS2 P35354 1/20 0.75
▸ HTR2B P41595 1/20 0.75
▸ MAPT P10636 8/20 0.63
▸ MEN1 O00255 5/20 0.63
▸ KMT2A Q03164 5/20 0.63
▸ AR P10275 1/20 0.63
▸ CYP3A4 P08684 5/20 0.57
▸ HPGD P15428 2/20 0.57
▸ HTT P42858 2/20 0.57
▸ CYP1A2 P05177 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylamine SCHEMBL27851138 1.00 HSD17B10 (0.80) HSD17B10TDP1ALDH1A1TSHRALOX12
Diphenylamine SCHEMBL8119680 1.00 HSD17B10 (0.80) HSD17B10TDP1ALDH1A1TSHRALOX12
Diphenylamine SCHEMBL27671770 1.00 HSD17B10 (0.80) HSD17B10TDP1ALDH1A1TSHRALOX12
Diphenylamine SCHEMBL8135380 1.00 HSD17B10 (0.80) HSD17B10TDP1ALDH1A1TSHRALOX12
Diphenylamine SCHEMBL29151847 0.97 HSD17B10 (0.75) HSD17B10TDP1ALDH1A1TSHRALOX12
Diphenylamine SCHEMBL1619083 0.89 HSD17B10 (1.00) HSD17B10TDP1ALDH1A1TSHRALOX12
Diphenylamine SCHEMBL301493 0.89 HSD17B10 (1.00) HSD17B10TDP1ALDH1A1TSHRALOX12
Diphenylamine SCHEMBL3003404 0.89 HSD17B10 (1.00) HSD17B10TDP1ALDH1A1TSHRALOX12
Diphenylamine SCHEMBL229 0.89 HSD17B10 (1.00) HSD17B10TDP1ALDH1A1TSHRALOX12
Diphenylamine SCHEMBL6828443 0.89 HSD17B10 (1.00) HSD17B10TDP1ALDH1A1TSHRALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0674232-B1 Recording sheets XEROX CORP (US) 2000-05-31 — — EP claimed
US-9107659-B2 Snap fit sling anchor system and related methods BOSTON SCIENTIFIC SCIMED, INC. (US) 2015-08-18 — — US disclosed
CN-102712572-B Method for obtaining 3, 3-diphenylpropylamine CRYSTAL PHARMA SAU 2014-08-27 — — CN disclosed
CN-103221512-A Oil release with n-auroyl amino acid-based compounds DU PONT 2013-07-24 — — CN disclosed
CN-102712572-A Method for obtaining 3, 3-diphenylpropylamine CRYSTAL PHARMA SAU 2012-10-03 — — CN disclosed
CN-102470110-A Transdermal composition comprising tolterodine SK CHEMICALS CO LTD 2012-05-23 — — CN disclosed
US-20120010462-A1 SNAP FIT SLING ANCHOR SYSTEM AND RELATED METHODS BOSTON SCIENTIFIC SCIMED, INC. (US) 2012-01-12 — — US disclosed
US-8043205-B2 Snap fit sling anchor system BOSTON SCIENTIFIC SCIMED, INC. (US) 2011-10-25 — — US disclosed
CN-100475775-C Highly pure bases of 3,3-diphenyl propylamine monoesters SANOL ARZNEI SCHWARZ GMBH (DE) 2009-04-08 — — CN disclosed
CN-101340946-A Pharmaceutical combination for the treatment of luts PFIZER (US) 2009-01-07 — — CN disclosed
EP-1909687-A1 SNAP FIT SLING ANCHOR SYSTEM AND RELATED METHODS Boston Scientific Scimed, Inc. (US) 2008-04-16 — — EP disclosed
US-20070015953-A1 Snap fit sling anchor system and related methods BOSTON SCIENTIFIC SCIMED, INC. (US) 2007-01-18 — — US disclosed
WO-2007008209-A1 SNAP FIT SLING ANCHOR SYSTEM AND RELATED METHODS BOSTON SCIENTIFIC SCIMED INC. (US) 2007-01-18 — — WO disclosed
CN-1802345-A Highly pure bases of 3,3-diphenyl propylamine monoesters SANOL ARZNEI SCHWARZ GMBH (DE) 2006-07-12 — — CN disclosed
CN-1767820-A Transdermal administration of (r)-3,3-diphenylpropylamine monoesters. SANOL ARZNEI SCHWARZ GMBH (DE) 2006-05-03 — — CN disclosed
EP-1021204-A2 BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS NOVEN PHARMACEUTICALS, INC. (US) 2000-07-26 — — EP disclosed
WO-1999015210-A2 BIOADHESIVE COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF ACTIVE AGENTS NOVEN PHARMACEUTICALS, INC. (US) 1999-04-01 — — WO disclosed
US-5240947-A Thrombocyte aggregation inhibitors, antiallergens NATIONAL SCIENCE COUNCIL (TW) 1993-08-31 — — US disclosed
EP-0511270-A1 NEW THIAZOLE DERIVATIVES CEDONA PHARMACEUTICALS B.V. (NL) 1992-11-04 — — EP disclosed
CN-85104453-A Prepare a kind of method that is used for the treatment of the tetrahydro naphthols of hypertension — 1986-12-10 — — CN disclosed
Send feedback